Geode Capital Management
KMTS

Geode Capital Management’s Kestra Medical Technologies KMTS Stock Holding History

Geode Capital Management’s Portfolio KMTS Stock Details KMTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11.4M Buy
573,925
+154,810
+37% +$3.65M ﹤0.01% 2305
2025
Q4 		$11.1M Buy
419,115
+87,753
+26% +$2.26M ﹤0.01% 2366
2025
Q3 		$7.87M Buy
331,362
+6,036
+2% +$108K ﹤0.01% 2552
2025
Q2 		$5.4M Buy
325,326
+285,579
+718% +$6.23M ﹤0.01% 2690
2025
Q1 		$990K Buy
+39,747
New +$913K ﹤0.01% 3308

Other funds holding KMTS

BCI
Bain Capital Investors Boston, Massachusetts $3.27B AUM 3.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AP
Andera Partners Paris $206M AUM
YF
Yu Fan $97M AUM 57.2% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management's KMTS Position: Q1 2026 in Review

Geode Capital Management increased its Kestra Medical Technologies (KMTS) stake by 37% in Q1 2026, buying an estimated $3.65M and bringing the position to 573,925 shares worth $11.4M. The position accounts for ﹤0.01% of the portfolio, ranked #2305.

Geode Capital Management first reported a position in KMTS in Q1 2025 and has held it in 5 quarters since. 103 funds tracked by Wall St. Rank hold KMTS as of Q1 2026.

  • Geode Capital Management held 573,925 shares of Kestra Medical Technologies worth $11.4M as of Q1 2026.
  • Geode Capital Management bought 154,810 Kestra Medical Technologies shares in Q1 2026, an estimated $3.65M.
  • Kestra Medical Technologies made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #2305 holding.
  • Geode Capital Management first reported a position in Kestra Medical Technologies in Q1 2025 and has held it in 5 quarters since.
  • 103 funds tracked by Wall St. Rank held Kestra Medical Technologies as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.